AN2 Therapeutics, Inc.
NASDAQ:ANTXBiotechnology
Healthcare
$5.22 +0.82%
+$0.04 today
- Market cap
- $198.07M
- Beta
- -0.98
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.01
52W Low $1.00High $6.91
Volume 0.79M
Average 0.29M
Price history
AN2 Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+383.33%
Period high
$6.28
Period low
$1.03
Latest
$5.22
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| 4 | Nov 6, 2026 | Nov 6, 2026 | |
| 4 | Oct 13, 2026 | Oct 13, 2026 | |
| 4 | Oct 13, 2026 | Oct 13, 2026 | |
| 4 | Oct 13, 2026 | Oct 13, 2026 | |
| 4 | Sep 16, 2026 | Sep 16, 2026 | |
| S-8 | Sep 14, 2026 | Sep 14, 2026 | |
| 4 | Sep 11, 2026 | Sep 11, 2026 | |
| 4 | Sep 8, 2026 | Sep 8, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Sep 2, 2026 | Sep 2, 2026 | |
| 3 | Aug 27, 2026 | Aug 27, 2026 |
Competitors
Who does AN2 Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about ANTX's filings, answered from its disclosures.
What is the latest ANTX filing?
The latest filing shown is SC 13G/A dated Nov 13, 2026.
How many recent filings does ANTX have?
Intrinsic Alpha currently shows 20 recent filings for ANTX.
Continue the stock analysis
Jump to another research area for this company.